Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in shares of United States Antimony Co. (NYSE:UAMY – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 45,197 shares of the company’s stock, valued at approximately $227,000.
Other institutional investors have also recently bought and sold shares of the company. CoreCap Advisors LLC acquired a new stake in shares of United States Antimony in the fourth quarter valued at approximately $27,000. Raymond James Financial Inc. acquired a new position in shares of United States Antimony during the 2nd quarter worth approximately $33,000. Geneos Wealth Management Inc. acquired a new position in shares of United States Antimony during the 3rd quarter worth approximately $49,000. Legal & General Group Plc bought a new stake in United States Antimony in the 2nd quarter valued at $51,000. Finally, Lincoln Capital LLC bought a new stake in United States Antimony in the 4th quarter valued at $58,000. Institutional investors and hedge funds own 9.49% of the company’s stock.
United States Antimony Stock Performance
UAMY opened at $11.15 on Wednesday. United States Antimony Co. has a fifty-two week low of $1.94 and a fifty-two week high of $19.71. The company has a market capitalization of $1.59 billion, a P/E ratio of -222.92 and a beta of 0.43. The stock has a fifty day moving average of $9.54 and a 200-day moving average of $8.25.
Analysts Set New Price Targets
Several equities research analysts have issued reports on UAMY shares. Weiss Ratings started coverage on United States Antimony in a report on Friday, March 20th. They set a “sell (d-)” rating for the company. B. Riley Financial increased their price objective on shares of United States Antimony from $9.00 to $11.00 and gave the company a “buy” rating in a research report on Tuesday, February 24th. HC Wainwright raised their target price on shares of United States Antimony from $10.25 to $11.50 and gave the stock a “buy” rating in a research note on Monday, March 23rd. Finally, Alliance Global Partners reaffirmed a “buy” rating on shares of United States Antimony in a report on Wednesday, February 11th. Five equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $9.17.
View Our Latest Research Report on UAMY
United States Antimony Company Profile
United States Antimony Corporation is a specialized mining and chemical company focused primarily on the production and processing of antimony and antimony-based compounds. The company operates its own extraction and milling facilities to recover antimony metal and antimony trioxide, which serve as critical raw materials in industries such as flame retardants for plastics and textiles, catalysts for chemical processes, and additives for glass and ceramics. In addition to antimony, United States Antimony maintains smaller-scale gold and silver operations in Mexico that provide supplementary revenue streams and diversification of its mineral portfolio.
Founded in the mid-20th century, United States Antimony has evolved from a singleāmine operator into a multinational enterprise with mining and processing sites in both the United States and Mexico.
Further Reading
Want to see what other hedge funds are holding UAMY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for United States Antimony Co. (NYSE:UAMY – Free Report).
Receive News & Ratings for United States Antimony Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for United States Antimony and related companies with MarketBeat.com's FREE daily email newsletter.
